STRC Research

STRC Gene Hearing Loss: Comprehensive Guide for Families

1 min read

STRC Gene Hearing Loss: Comprehensive Guide

Context: Research for Egor’s son, diagnosed with moderate bilateral sensorineural hearing loss caused by compound heterozygous STRC gene mutations.

Key Findings

  • STRC-related hearing loss (DFNB16) is 2nd most common hereditary hearing loss
  • Affects ~2.3M people worldwide
  • Typically congenital, bilateral, mild-to-moderate (40-50 dB), generally STABLE over lifetime
  • Hair cells remain ALIVE and structurally intact (just lack stereocilin protein)
  • This creates broad window for future gene therapy (infancy through adulthood)

Treatment Horizon

  • Dual-AAV gene replacement restored hearing in mice
  • OTOF gene therapy restored hearing in dozens of deaf children (2022-2025 trials)
  • Regeneron has preclinical STRC program (AAV.104) in pipeline
  • Hearing aids: standard of care, highly effective for moderate loss

Files

  • English: ~/DeepResearch/2026-02-07-strc-hearing-loss-treatment.md
  • Russian: ~/DeepResearch/2026-02-07-strc-hearing-loss-treatment-RU.md

Connections

  • [see-also] Sound Therapy and Hearing Loss

  • [see-also] Misha Medical Timeline

  • [see-also] Gut-Brain Axis and Neurodevelopment

  • [see-also] Misha 6-Month Action Plan 2026 (Brain)

  • [see-also] DR — Misha French Social Protection (Brain)

  • [see-also] Misha Diagnostic Assessments (Brain)

  • [see-also] Misha Therapy Providers HK (Brain)

  • [see-also] France MDPH Disability Benefits

  • [see-also] Misha Psychologist Session 2026-02-27 (Brain)

  • [see-also] Allergy-Inflammation-Behavior Pathway (Brain)

  • [see-also] DR — Misha ADHD/ASD/Hearing Loss Management HK (Brain)

  • see sources/2026-02-07-strc-diagnosis-vus-guide.md

  • see sources/2026-02-07-strc-practical-guide-hk.md

  • Egor Lyfar - personal/family context

Graph View